Try our Advanced Search for more refined results
Life Sciences - August, 2022
340 articles
- Delay Tactic May Be Outcome Of DC Circ.'s FCA Liability Rule
- Canadian Pot Co. Investors Win Class Cert. In Acquisition Suit
- Calif. Stem Cell Clinic Isn't Subject To FDA Rules, Judge Says
- Inflation Reduction Act Paves Way For Drug Pricing Reform
- 3rd Circ. Nixes Sanctions Over Lab's 'Aggressive' Actions
- ABA Stance On Role Of Nonlawyers Is Too Black And White
- The Fed. Circ. In August: Considerations In Assignor Estoppel
- 5th Circ. Ruling Highlights Split On Ch. 11 Exculpation
- Philips To Pay $4M Over Claims It Skirted Military Testing Rule
- Clariant To Sell Chemical Biz To Own Joint Venture For $113M
- FDA Clears The Way For Moderna, Pfizer Omicron Boosters
- Sterigenics Rep Says It Didn't Need To Warn Of Emission Risk
- Feds Rip Exec's 'Culture Of Lies' As COVID Fraud Trial Wraps
- NY AG Wants Info On CVS, Walgreens Reproductive Care
- Eli Lilly Verdict Offers Insight Into FCA Scienter Battle
- Mississippi Diabetes Treatment Price Suit Mostly Survives
- Fla. Lab Owner Charged In NJ With $53M Medicare Fraud
- Iancu Downplays Patent Counts For Measuring IP Competition
- Investors Spar Over Ionis Director Pay Suit Deal In Chancery
- Firm Yanks Atty From Ga. Clinic FCA Suit After DQ Bid
- Medical Providers Must Brace For More DOJ Opioid Probes
- Harnessing The Power Of Big Data In Litigation
- Del. Jury Awards $2.3M Over Bone Imaging IP Infringement
- Gov't Denies Liability For Radioactive Injury Indemnity
- Judge Trims Some State Law Antitrust Claims From Lye Suit
- Roche Loses Appeal Against Generic Co. At China's Top Court
- Hartford Loses Bid To Undo Deal In MRI Explosion
- CR Bard Owes $4.8M To Hernia Mesh Patient, Jury Says
- FTC Brings Privacy Suit Against Co. Challenging Its Authority
- High Court Told Gov't Gave Up Chance To Dismiss FCA Case
- How Law Firm Operations Can Adjust To New COVID Realities
- J&J Fraud Suits Can Continue Despite Imerys Ch. 11 Stay
- Olympus Sells Microscope Biz To PE Firm In Nearly $3.1B Deal
- 'Wrong Message' To Free Ex-Insys Exec Early, Judge Says
- Med Tech Co. Says Ex-Worker Swiped Trade Secrets For Rival
- NY Law Firm Hit With Malpractice Suit By Health Care Co.
- J&J Must Face Pelvic Mesh Suit After 6th Circ. Reversal
- Formulation Patent Strategies Carry Untapped Potential
- O'Melveny Adds Longtime Life Sci IP Litigator From Honigman
- GrayRobinson Adds Ex-Morgan & Morgan Atty In Orlando, Fla.
- 3 Questions As Moderna Wages COVID Patent Attack On Pfizer
- Sterigenics Could Have Cut Toxic Emissions Earlier, Jury Told
- Assessing The Criminal Implications Of State Abortion Bans
- Fed. Circ. Affirms PTAB Ax Of Cancer Screening Claims
- Carestream Gets Approval For $85M Ch. 11 Exit Loan Deal
- Food, Drug, Cosmetic Cos. Should Expect More Additive Suits
- 4 More Small IPOs Tap Public Markets For $62M Combined
- Convicted Seller Of Racehorse PEDs Asks For No Prison
- Law Of The Case Is More Nuanced Than You May Think
- Don't Miss It: Skadden, Kirkland Guide Week's Hot Deals
- UK Litigation Roundup: Here's What You Missed In London
- Moderna Lobs COVID Vaccine IP Suit At Pfizer, BioNTech
- 9th Circ. Gives Allergan 2nd Chance To Ax FCA Suit
- Gilead Fights High Court Bid Over 'Possession' Of Invention
- Genomics Co. Parse Targeted In Patent Suit From 10x
- Tepezza Label Silent On Serious Hearing Risks, Suit Says
- Engage Associates At Orientation With Thoughtful Activities
- 8th Circ. Says Biomet Received A Fair Trial In Hip Implant Suit
- NJ Justices Toss Punitive Claims Over FDA Device Warning
- Centene Strikes $33M Deal To End Wash. Medicaid Fraud Suit
- Wilson Sonsini Adds Former In-House Atty To New York Office
- Gilead Sciences Owes $2M Sponsor Fee For Canceled Series
- Novartis To Spin Off $9.6B Sandoz Generic Drugs Biz
- COVID-19 Tort Cases Have Peaked, Report Says
- Idaho Blocked From Enforcing Abortion Ban In Emergencies
- Ex-Clinic Exec Asks Judge To Disqualify Counsel In FCA Suit
- Health Issues To Watch In Inflation Act, Other Policy Initiatives
- Small IPOs Buck Trends In An Otherwise Cold Market
- Evidence Rule Changes Help Judges Police Expert Testimony
- Court Lets Carestream Tap $50M, Tells Exit Lenders To Wait
- Texas Prosecutors Face Abortion Ban Enforcement Challenge
- Clark Love Sued Over 'Scheme' To Settle Expired Mesh Suits
- A Federal Data Privacy Law Is The Disaster We Urgently Need
- Texas Wins Halt Of HHS' Emergency Abortion Care Guidance
- The Cruciality Of Building Client Intimacy Ahead Of Recession
- Bard Tells Mesh Jury Patient Didn't Prove What He Promised
- 11th Circ. Says FDA Must Weigh Youth Vape Restriction Plans
- Inovio Inks $44M Cash, Stock Deal To End COVID-19 Vax Suit
- 5 Amici Back Drug Cos. Fighting Denial Of Patent Review
- Foley Snags Antitrust Partner From Colo. AG's Office
- Ch. 11 Cheat Sheet: Carestream Health Inc.
- Curaleaf Renews Quest To End Workers' Stolen Tips Suit
- Essilor Will Pay $22M To End Doctor Kickback Claims
- How To Win Over Bench Trial Judges Post-COVID
- Ex-Vitamin Shoppe CFO's Retaliation Claims Tossed In NJ
- Becton Dickinson Gets Drug Transfer System IP Suit Tossed
- Medical Imaging Co. Carestream Hits Ch. 11 With $1B Of Debt
- These Firms Have The Most Women In Equity Partnerships
- Indivior Loses Bid For Early Win In 'Product Hop' MDL
- Pharmacies Can't Be Forced To Fill Ivermectin Rx, Judge Says
- Court Won't Block Plan To Sell Cloned Polo Horses
- Vaxart Investors Seek Initial OK Of $12M Deal In Fraud Suit
- Ex-Amarin Pharma Exec Denied Quick Win Over Noncompetes
- PTAB Denies Chinese Co.'s IPR Targeting Cultured Cell Patent
- Anti-Abortion Activists Lose At 9th Circ. In Video Row
- Bayer AG CEO Ordered To Testify In Roundup Case
- Endo Unit Seeks To Stop Termination Of Drug License Deal
- Actavis Can Deduct $12M In Legal Fees, Claims Court Says
- J&J Talc Unit Gets Nonprofit Assist In Fight To Keep Ch. 11
- Pay Expert Cops To Taking Illegal $400K Insider Payday
- A Cautionary Tale On Diversity Jurisdiction From The 6th Circ.
- High Court Wants Gov't View On Controversial FCA Case
- Quest's Virus Row Stays In Wash. As AIG's NJ Suit Is Tossed
- Catching Up With Delaware's Chancery Court
- Medical Imaging Startup Soars In Shanghai After Smash IPO
- Judge Rejects Bid Protections For GenapSys Stalking Horse
- Ex-MiMedx Execs Can't Undo Fraud Convictions At 2nd Circ.
- A Deep Dive Into The Glass Ceiling Report: Women In Law
- Monsanto Mgr. Tells Jury Roundup Study Edits 'Suggestions'
- NY Court Told It Can't Ax Swiss Medical Imaging Award
- GSK Says Teva's Skinny-Label Row Is 'No Threat' To Generics
- Insuring Psychedelic Therapy Key To Promising Industry
- Don't Miss It: Goodwin, Cooley Guide Week's Hot Deals
- Medical Supply Co. Gets $5M In Nursing Home Fraud Case
- EFF Says Tillis Bill Would Bring Back 'Worst Patent Abuses'
- Judge Denies Ch. 11 Dismissal Try By GenapSys Founders
- Colo. Pharma Co. Faces Securities Suit Over Drug Claims
- Former Amarin Exec's Noncompete Brawl Likely Not Over Yet
- Overly Broad PFAS Regs Bring Costs For Companies
- Stockholder Sues Pharma Co. For Docs On $149M Merger
- A Jump Forward For Fla. Pharmacy Technicians' Vax Authority
- Drug Impairment Testing Deemed Reliable In NJ Case
- Goodwin-Guided Kymera Raises $150M With Share Sale
- DOJ Filing Reawakens Fraud-On-The-FDA Theory Of Liability
- Australian Beverage Co. Plans To Tap US Market For $20M IPO
- UK Litigation Roundup: Here's What You Missed In London
- Sterigenics Polluted Ill. Village For Decades, Jury Hears
- Lanier On $650M Opioid Win: I'd Have Settled For 'A Lot' Less
- Endo Noteholders Say Alternative Ch. 11 Plan Needed
- Nicotine Firm Gets First-Ever Warning For Marketing Gummies
- Vidal Takes Up Boehringer's Failed Pig Vaccine IP Challenge
- Teva Found To Infringe Vifor Fresenius Kidney Drug Patent
- 3rd Circ. Denies Doc's Bid For New Trial In $100M Fraud Case
- Westco Gets Early Win In 'Secret' Pension Plan Suit
- Fed. Circ. OKs Eagle's Generic Vasostrict In Loss For Endo
- Using Bayh-Dole To Control Drug Prices Would Skew Statute
- Strategies For Improving Diversity In Psychedelics Research
- CBD Supplement Buyers, Maker Spar Over Resuming Suit
- Endo Beats Investors' Opioid Crisis Class Action, For Good
- Supplement Makers Reach Patent Deal After Amazon Fight
- 1st Circ. Says Dormant Commerce Clause Applies To Med. Pot
- Key Factors In Determining Specific Personal Jurisdiction
- Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art
- Surescript's EpiPen Citation 'Nothing New,' FTC Says
- J&J Talc Unit Defends 'Valid' Ch. 11 Filing At 3rd Circ.
- Zantac Plaintiff Dismisses Suit 1 Week Before Trial
- 6th Circ. Refuses To Double Atty Fees From Pharmacy's Ch. 7
- Paul Hastings Tech M&A Pro Joins Baker Botts In Palo Alto
- Del. Suit Alleges Insider Trades Worth $171M By Nektar Execs
- Orrick Adds Partner In Transactional Tax
- Longtime Hogan Lovells Partner Jumps To Mayer Brown In DC
- CVS, Walmart, Walgreens Owe $650M In Ohio Opioid Fallout
- Endo Hits Ch. 11 Amid Opioid Suit Crush
- 'Sea Change In The Law': Inside One Firm's Post-Roe Practice
- Software Biz Urges Fed. Circ. To Revive License Breach Deal
- Merck's Zetia Arguments Don't Misuse Privilege, Judge Says
- Co. Fights 'Serial Objector' Claim In Settlement Of Ad Case
- Idaho Co. Fights FTC's Suit Threat Over Data Tracking
- Biden Signs Landmark Tax And Climate Bill Into Law
- After NY Asbestos Rulings, Lung Cancer Suits Face Obstacles
- What Litigators Can Really Learn From Rambo
- Kirkland-Guided Thompson Street Closes $1.5B Fund
- Eton Infringes Preterm Infant Drug Patents, Del. Judge Rules
- Fed. Circ. Urged To Toss Pot Co.'s CBD Patent Appeal
- Mass. Health Network, Insurer Settle Over Scientist's Award
- 1st Circ. Partially Resurrects Azurity's Beef With Edge Pharma
- NY AG Rips 'Secret' Info From 'Besmirched' Arnold & Porter
- Okla. Court Fit For Cherokee Opioids Suit, 10th Circ. Told
- McKesson Hid Sales Data In FCA Suit, Whistleblower Says
- Justices Urged To Reject Review Of Biogen MS Drug IP Ruling
- Justices Told Generic Drugs At Risk From Skinny Label Ruling
- NCAA Hit With Concussion Class Action By Ex-FSU Player
- Catching Up With Delaware's Chancery Court
- Attorneys Should Note Judges' Financial Conflicts Of Interest
- Protein Products Recall For Deadly Germ Sparks Class Suit
- Joint Juice Maker Hit With $12.8M In Statutory Damages
- Ex-Virginia Assistant AG Joins Cozen O'Connor
- A Guide To Navigating Bankruptcy's Impact On IP Licenses
- Senate Cannabis Bill May Give Some Cos. A Competitive Edge
- Covington Hires Former FDA Atty From Sidley
- Monsanto Atty Grills Oncologist On Roundup Usage Numbers
- New Patent Bill Could Boost Diagnostics, But Needs Work
- Becton's Former CEO And CFO Escape Securities Suit
- Appalachia Opioid Charges Dropped After High Court Ruling
- Big Pharma Expected To Put Up Fight Over Drug Negotiations
- Enforcing Patents Isn't Easier As America Invents Act Turns 10
- House Sends Landmark Tax And Climate Bill To Biden
- Investors Sue Pharma Co. In Chancery Over Diabetes Drug
- Jones Day, Ropes & Gray Lead $950M HIG-Avient Deal
- Gordon & Rees Brings On Asbestos Expert In California
- Pa. Cannabis Banking Law Won't Allay Finance Industry Fears
- Pharma Exec Admits Lying To FDA About Weight-Loss Drug
- A Law Firm's Guide To Avoiding Client Conflicts
- Expect More DOJ Labor Market Enforcement, Despite Losses
- Nursing Homes Must Brace For Data-Driven DOJ Scrutiny
- Seagen Eyes $12M In Atty Fees On Top Of $42M Daiichi Verdict
- The Defense Bar Must Push Back On Social Inflation
- Health Hires: WelbeHealth, Enzo Biochem, CooperCompanies
- UK Litigation Roundup: Here's What You Missed In London
- Feds Aim For More Insight On Hacks With Maze Of Policies
- Calif.'s Broad Nuisance Law Key To Walgreens Opioid Liability
- Winless In Opioid Bouts, Will Pharmacies Throw In The Towel?
- J&J To Halt Global Talc Baby Powder Sales In 2023
- Full Fed. Circ. Won't Mull USPTO Interim Director's Powers
- W.Va. Reaches Opioid Deal With Rite Aid Worth Up To $30M
- Fed. Circ. Still Won't Let Minerva Invalidate Hologic Patent
- HHS Wants 3rd Circ. To Revive Drug Discount Violation Notice
- Montana High Court Blocks State's Anti-Abortion Laws
- Surgical Robot Co.'s Antitrust Fight Heads To Dec. Trial
- 5th Circ. Backs CR Bard Win Over Vein Filter Implant Design
- Viatris Asks Fed. Circ. To Revive Hypertension Drug IP Fight
- Anti-Kickback Circuit Split Holds Implications For Defendants
- Judge Issues Mixed Ruling In Salix, Norwich Patent Row
- Zicam Inventor Charged With 'I Love Lucy' TV Co. Scam
- Wilson Sonsini Lures IP Atty To Boulder, Eyes Colo. Growth
- Understanding DC Circ.'s Agency Rule Withdrawal Debate
- NJ Atty Booted From Pharma Co.'s Herbal Extract TM Row
- Garland Defends FBI, Moves To Unseal Trump Search Warrant
- Lessons For Federal Lawmakers As Calif. Alters Cannabis Tax
- Flint Case Ends In Mistrial After Jurors Cite Mental Health
- 9th Circ. Backs Arbitration Order In Tribe's Rx Payback Case
- Endo Teeters On The Edge, Revlon Equity Committee Sought
- Big Tobacco Wins 8th Delay Of Graphic New Warning Labels
- Skadden, Fried Frank Build $475M Sale Of Mayne Pharma Unit
- Considerations For Associates As Lateral Hiring Cools Down
- Allergan Must Comply With Implant MDL Discovery
- Rx Delivery Co. Prescribes Toss For Data Breach Suit
- Walgreens Fueled SF Opioid Epidemic, Judge Rules
- Sartorius To Acquire Albumedix For £415M
- Anti-Abortion Activists Ask 9th Circ. To Nix Videos Injunction
- Mylan Gets Industry Aid In $50M Tax Fight At 3rd Circ.
- Endo Says Bankruptcy Likely In Face Of Opioid Suits
- Amgen Looks To Duck Regeneron's Bundling Suit
- Latham, Kirkland Lead $718M Sale Of Huntsman's Textile Biz
- Chancery Splits Trial On Biopharma Co. Plasmid Supply Suit
- 7th Circ. View Of FCA Intent Is 'Deeply Flawed,' Justices Told
- Ionis Investor Seeks Fee For Director Pay Suit Deal In Del.
- Viatris Can't Keep Novo's Weight Loss Drug IP Suit In W.Va.
- NC Drugmaker Seeks OK Of Ch. 11 Deal With Distributor
- Feds Want Exec's Advice-Of-Counsel Fraud Defense Barred
- Flint Judge Steps Aside During Deliberations Due To Health
- Justices' EPA Ruling Didn't Move Needle On Chevron Doctrine
- Hemp Biotech Co. Aims To Nix Suit After 2nd Circ. Revival
- Actavis Keeps Trial Win In Man's Heart Attack Suit
- Exec Defrauded Medicare With COVID Test Lies, Jury Told
- Judge Trims Pfizer, Mylan EpiPen Antitrust Suit
- DOJ Says Medical Pot Patients Have No Right To Bear Arms
- Biopharma Co. Accused Of Lying To Investors About FDA Hold
- Trump Says FBI 'Raided' His Mar-A-Lago Resort
- Radius Health Investor Sues To Probe $890M Merger
- Eisai Wins Ax Of Sleep Drug Patent Claims At PTAB
- Mallinckrodt Noteholders Seek End To Default Payment Appeal
- Catching Up With Delaware's Chancery Court
- Health Co. Accused Of Stealing Psilocybin Therapy Idea
- 2nd Circ. Partially Revives Bausch Lens Case
- 3 Firms Shape Pfizer's $5.4B Deal For Sickle Cell-Drug Maker
- CVS Can't Escape HIV Patients' Disability Bias Suit
- Senate Sends Dems' Landmark Tax, Climate Bill To House
- Walmart, CVS, Walgreens Ask 10th Circ. To Pause Opioid Suit
- 1st Circ. Won't Revive Karyopharm Investors' Stock-Drop Suit
- Benicar Plaintiffs Appeal Axing Of Fee Suit To 3rd Circ.
- Landmark Opioid Opinion 'Not Persuasive,' W.Va. Panel Says
- After Dobbs: Kan. Voters, DOJ Fight Abortion Restrictions
- Scouts' Plan Mostly Approved, Jones Hit With $50M Verdicts
- Medtronic Inks Deal To End Faulty Pacemaker Suit
- Ethics Lessons From The Alex Jones Discovery Debacle
- Boston Scientific Reaches Deal To End Implant Death Suit
- The Role Of Morality In IP Suits Over COVID-19 Vaccines
- Profs Urge Full Fed. Circ. To Review 'Startling' Novartis Ruling
- Suits Over Tainted Abbott Baby Formula Join Illinois MDL
- Ex-FDA Veteran Joins Sidley In DC
- In-House At A Cannabis Company: The Advertising Issues
- Nixon Peabody Names Global Finance Co-Leaders
- Priest's Prayer For New Stock Fraud Trial Goes Unanswered
- UK Litigation Roundup: Here's What You Missed In London
- Monkeypox Deemed National Emergency As Cases Near 7,000
- Shareholders Lose Lawsuit Over Diabetes Drug Delay
- Cooley Atty Ordered To 'Personally Pay' For 'Hubris'
- Philips' IP Suit Over Ultrasound Co.'s Alleged Hacking Stands
- Feds Say Ex-Insys Executive Doesn't Deserve Early Release
- Gardasil Vax Suits Sent To North Carolina
- Wachtell, Latham & Watkins Steer $3.7B Biopharma Deal
- Farm Tells 4th Circ. Water Act Citizen Suit Should Get Boot
- 3rd Circ. Says Court Must Revisit Arbitration In OptumRx Case
- Agriculture Patent Reform Can Look To Pharma Approaches
- Dobbs, Workers' Comp. Brief Hint At Biden's Cannabis Stance
- UnitedHealthcare Senior Atty Joins Centivo As 1st GC
- AIG Unit Owes Coverage For Illinois Toxic Emissions Suits
- Combating Implicit Bias In Alternative Dispute Resolution
- Jones Day Adds Biotech Pro From Baker Botts In NY
- GenapSys Founders Win Delay On Bankruptcy Sale, Loan
- Robbins Geller Nabs $13.5M In Puma Biotech Investor Suit
- Arnold & Porter Names Head For New Amsterdam Office
- Patent Eligibility Bill May Clarify Law But Spur New Fights
- Monsanto Faces 1st Mo. Jury Over Roundup Users' Cancers
- Biden Issues Another Order To Protect Abortion Access
- Implant Co. Reaches $2M SEC Deal As Ex-CEO Stands Ground
- Ex-UChicago Professor Avoids Prison For Insider Trading
- These Abortion Ballot Measures Are Next After Kansas Vote
- How The Metaverse Will Affect Business And Legal Processes
- Steptoe & Johnson Adds Gov't Contracts Partner
- Bayer, Buyers Get Go-Ahead On $2.3M Sunscreen Settlement
- Eli Lilly Must Pay $61M For False Medicaid Rebate Calculation
- Cannabis Grower Wants Out Of Ark. THC Potency RICO Suit
- AstraZeneca, Bristol Myers, McKesson Snag Early Win In MDL
- Eli Lilly 'Proud' Of Drug Rebate Specialist's Process
- Sofia Vergara's Ex Tells Panel Jury Should Hear Embryo Suit
- 3rd Circ. Won't Increase Prison Term For GSK Researcher
- This Week's Regulatory Hires Span Finance, Gaming, Health
- Attorneys Get $13M In Fees For Mallinckrodt Securities Deal
- Trans W.Va. Medicaid Participants Win Bias Suit
- W.Va. County Appeals Opioid Bellwether Ruling
- Biotech Co. Sironax Raises $200M In Series B Funding
- DOJ's Fraud-On-The-FDA Liability Theory Is Problematic
- Mylan Asks 3rd Circ. To Uphold Win In $50M Tax Fight
- J&J Should Get $18M For 'Horrific' Counterfeits, Judge Says
- Garland Outlines Abortion Protections In New Post-Dobbs Suit
- Kirkland-Led KKR Sells Rubber, Plastics Biz In $950M Deal
- Merck Blasts Teen's Gardasil Suit As 'Anti-Vaxxer' Rhetoric
- Cooley Reps VC Firm On $122M Cancer Medicine Co. Funding
- What Cannabis Cos. Can Expect If Broadcast Ad Bill Passes
- Cherokee Say Okla. Court Should Proceed With Opioid Suit
- Monsanto Looks To Undo 11th Circ. Roundup Ruling
- W.Va. AG Inks $400M Deal With Drug Distributors Over Opioids
- Product Liability Cases To Watch: Midyear Review
- Biopharma Co. Board Sued In Del. For Blocking Director Slate
- 11th Circ. Won't Revive Investor Suit Against Med Tech Co.
- Gov't Contracts Of The Month: Internet In Space, Fall Vaccines
- 7th Circ. Declines To Revive Humira 'Patent Thicket' Claims
- Boston Scientific To Pay $85M To End Nevro Patent Litigation
- Imminent Tillis Bill Expands Eligibility, Protects Diagnostics
- Gordon & Rees Hires Health Care Partners For Raleigh Office
- Navigating Arbitral Subpoenas In A Post-COVID Landscape
- Judge Won't Toss $950M COVID-19 Vax Trade Secrets Row
- Prepare For Scrutiny In Marketing Contraception After Dobbs
- WilmerHale, Simpson Drive $2.45B Deal For PerkinElmer Units
- Pa. Panel Lets Hotel Next Door Set Pittsburgh Tower's Height
- Hospital Strikes $10.3M Deal In Religious Workers' Vax Suit
- Winston & Strawn Health Care Co-Chair Joins DOJ
- Bristol-Myers Says Its Former Lawyer Can't Testify In IP Battle